Treatment with anti-spike monoclonal antibodies in allogeneic HCT and CAR T-cell recipients with mild to moderate COVID-19: The Mayo Clinic experience

Mohty, R.; Thoendel, M.; Swei, S.; Bansal, R.; Palmer, J.; Hogan, W. J.; Vergidis, P.; Munoz, J.; Iqbal, M.; Yassine, F.; Bennani, N. N.; Hathcock, M.; Murthy, H. S.; Castro, J. E.; Lin, Y.; Razonable, R. R.; Kharfan-Dabaja, M.

Mohty, R.; Thoendel, M.; Swei, S.; Bansal, R.; Palmer, J.; Hogan, W. J.; Vergidis, P.; Munoz, J.; Iqbal, M.; Yassine, F.; Bennani, N. N.; Hathcock, M.; Murthy, H. S.; Castro, J. E.; Lin, Y.; Razonable, R. R.; Kharfan-Dabaja, M..

Journal of Clinical Oncology ; 40(16), 2022.

Article in English | Web of Science | ID: covidwho-2092764

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Language: English Journal: Journal of Clinical Oncology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Language: English Journal: Journal of Clinical Oncology Year: 2022 Document Type: Article